← Oncology Approval Tracker

FDA DECISION ·

Pemetrexed injection

pemetrexed · Actavis

FDA approvalNew formulationNon-small cell lung cancer
Open LinkedIn brief ↓

1 min read · estimated

Sources

APPROVED USE

What FDA approved

Single-agent maintenance of locally advanced or metastatic nonsquamous non-small cell lung cancer without progression after four first-line platinum cycles, or treatment of recurrent metastatic nonsquamous disease after chemotherapy.

LAMPGEN ANALYSIS

Why it matters

Added a separately approved pemetrexed presentation for selected nonsquamous lung cancer uses.

What research teams should watch

Use product-specific dilution instructions and verify that the intended regimen matches this label.

PRIMARY RECORDS

Sources